eflornithine has been researched along with Meningeal Neoplasms in 1 studies
Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.
Meningeal Neoplasms: Benign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deen, DF | 1 |
| Chiarodo, A | 1 |
| Grimm, EA | 1 |
| Fike, JR | 1 |
| Israel, MA | 1 |
| Kun, LE | 1 |
| Levin, VA | 1 |
| Marton, LJ | 1 |
| Packer, RJ | 1 |
| Pegg, AE | 1 |
1 other study available for eflornithine and Meningeal Neoplasms
| Article | Year |
|---|---|
Brain Tumor Working Group Report on the 9th International Conference on Brain Tumor Research and Therapy. Organ System Program, National Cancer Institute.
Topics: Adult; Animals; Antineoplastic Agents; Brain Neoplasms; Child; Child, Preschool; Clinical Trials as | 1993 |